Newsweek Examines Antimicrobial Resistance, Efforts To Develop Financial Incentives, Innovate New Disease-Fighting Methods

Newsweek: The Death Of Antibiotics: We’re Running Out Of Effective Drugs To Fight Off an Army of Superbugs
“…There’s little in the pharmaceutical pipeline to replace the antibiotics to which bugs are becoming resistant. That’s because development of a new antibiotic runs about $2 billion and takes about 10 years — with little hope of ending up with the sort of blockbuster drug that justifies such an investment. … Medical researchers are now searching for other approaches…” (Freedman, 5/15).

Newsweek: Doctors Are Running Out of Effective Drugs Because of Poor Financial Incentives to Develop Them
“…Although researchers have many good leads, the bigger problem is a lack of financial incentives to bring new treatments through the drug-development gantlet. ‘When I signed up to be an infectious disease specialist 25 years ago, I never thought it would come to this,’ says Helen Boucher, a physician at Tufts Medical Center in Boston and director of its infectious disease fellowship and heart transplant programs. Boucher has been a leading advocate for finding ways of investing in new treatments. She spoke with Newsweek about the drug-resistance problem and how we might dig our way out of it…” (Freedman, 5/15).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270 | Email Alerts: | |

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.